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Background: Obesity in infancy and adolescence has acquired epidemic dimensions worldwide and is considered
a risk factor for a number of disorders that can manifest at an early age, such as Metabolic Syndrome (MS). In this
study, we evaluated overweight, obese, and extremely obese adolescents for the presence of MS, and studied the
prevalence of single factors of the syndrome in this population.
Methods: A total of 321 adolescents (174 females and 147 males) aged 10 to 16 years, attending the Adolescent
Outpatient Clinic of Botucatu School of Medicine, Brazil, between April 2009 and April 2011 were enrolled in this
study. Adolescents underwent anthropometric evaluation (weight, height, and abdominal circumference) and Body
Mass Index (BMI) was estimated according to age and gender, following Disease Control and Prevention Centers
recommendations (CDC, 2000). Blood pressure was measured and individuals with BMI ≥ 85th percentile were
submitted to laboratory evaluation for Total Cholesterol, HDL and LDL Cholesterol, Triglycerides, Fasting Insulinemia,
and Fasting Glycemia to identify MS factors, according to the criteria suggested by the International Diabetes
Federation. Insulin resistance was calculated by HOMA-IR, Quicki, and Fasting Glycemia/Fasting Insulinemia (FGI).
Results and discussion: Of the 321 adolescents, 95 (29.6%) were overweight, 129 (40.2%) were obese, and 97
(30.2%) were extremely obese. Around 18% were diagnosed with MS. The most prevalent risk factors were
abdominal circumference ≥90th percentile (55%), HDL < 40 mg/dL (35.5%), High Pressure ≥130/85 mm/Hg (21%),
Triglycerides ≥150 mg/dL (18.5%), and Fasting Glycemia ≥100 mg/dL (2%). Insulin resistance was observed in 65%
of the adolescents.
Conclusion: An increased prevalence of overweight and obesity, together with cardiometabolic risk factors such as
dyslipidemia and abnormal blood pressure, were observed in adolescents, contributing to the onset of metabolic
syndrome at younger ages. Risk factors for MS were more prevalent in females.
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Obesity in infancy and adolescence has acquired epi-
demic proportions worldwide, with a high prevalence in
both developed and developing countries [1]. It is consid-
ered a risk factor for a number of serious disorders, such
as Metabolic Syndrome (MS), which can manifest at
early ages. MS consists of a group of metabolic abnor-
malities, and according to the International Diabetes
Federation (IDF), characteristics of this syndrome include* Correspondence: tamara@fmb.unesp.br
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reproduction in any medium, provided the orobesity, with emphasis on excess abdominal fat, hyper-
tension, dyslipidemia, and hyperglycemia [2]. Insulin re-
sistance seems to be the physiopathological basis for MS
and hyperinsulinemia is considered a precursor for MS.
Weight gain is an independent predictor for MS develop-
ment although not seen in all obese individuals [2].
Recently, the potential consequences of obesity and
metabolic syndrome in adolescents have gained greater
attention. Studies have shown that the factors of MS,
which are abnormal in infancy, often persist throughout
adulthood [2-4]. The prevalence of MS among adoles-
cents in the United States has increased over recent
years, from 9.2% in the period from 1988 to 1994, totd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in the cutoff points adopted by different authors and a
lack of consensus in defining the risk factors for MS,
prevalence can vary according to the definition used and
the population studied [2,3,6].
The criteria for diagnosing MS in children and adoles-
cents have been established by the IDF [2]. They are spe-
cific according to age ranges between 6 and 10 years,
between 10 and 16 years, and 16 years and over. It has
been suggested that Metabolic Syndrome should not be
diagnosed in children under 10 years old, but a reduc-
tion in body weight should be encouraged in those with
central obesity. Between 10 and 16 years, MS can be
confirmed by central obesity, defined using the 90th per-
centile values of waist circumference for gender and age,
associated to other two factors (elevated triglycerides,
low HDL cholesterol, arterial hypertension, and hyper-
glycemia). Diagnosis criteria for adolescents of 16 years
or above are similar to those for adults.
This study aimed to evaluate overweight, obese, and
extremely obese adolescents for the presence of MS, and
to establish the prevalence of each factor of the syn-
drome in the population analyzed.
Materials and methods
Adolescents between 10 and 16 years old, of both gen-
ders, registered at the Adolescent Outpatient Clinic,
Botucatu School of Medicine – UNESP, Brazil, between
April 2009 and April 2011, were invited to participate in
the study. Their parents or guardians signed an informed
consent form. The study was approved by the Research
Ethics Committee of Botucatu School of Medicine –
UNESP, protocol 357/08 CEP. The age group was
chosen following the criteria proposed by the IDF [2].
Participants underwent clinical examination, including
anthropometric [7] and nutritional evaluation. Nutritional
status was evaluated using Body Mass Index (BMI) curves,
weight (kg)/height2 (m), according to age and gender, and
the respective cutoff points proposed by the Centers for
Disease Control and Prevention, which are: eutrophic be-
tween the 5th and 85th percentiles; overweight or, according
to CDC [8] guidelines, “at risk of overweight,” greater than
or equal to the 85th percentile and less than the 95th per-
centile; and obese, or according to CDC [8], “overweight,”
above the 95th percentile [8]. In this study, we used the
terms overweight and obese. Participants with gender- and
age-adjusted BMI above the 99th percentile were classified
as extremely obese [9]. Abdominal circumference (AbdC)
was measured at the midpoint between the iliac crest and
the last rib [9-11]. These values were compared with the
90th percentile values of waist circumference according to
age and gender, using the curve proposed by Fernández
et al. [10]. Blood (BP), Systolic (SBP), and Diastolic (DBP)
pressure were measured.Participants considered overweight, obese, or extremely
obese by BMI calculation (n = 321) were submitted to la-
boratory exams for total cholesterol and fractions, trigly-
cerides, basal insulinemia (also called fasting insulinemia),
fasting glycemia, free Thyroxinemia (free T4), and thyroid
stimulation hormone (TSH), to evaluate the presence of
diagnostic criteria for MS or another disease. Values pub-
lished by IDF for this specific age group are Triglycerides
(TG) ≥150 mg/dL, or specific treatment for this abnor-
mality; HDL cholesterol (HDLc) <40 mg/dL for both
sexes, or specific treatment for this abnormality; arterial
hypertension with SBP ≥ 130 mmHg or DBP ≥ 85 mmHg
or specific treatment for arterial hypertension; and fast-
ing glycemia ≥100 mg/dL or a previous diagnosis of type
2 diabetes [2].
Fasting glycemia and fasting insulinemia values were
used to calculate HOMA-IR (Homeostasis model assess-
ment of insulin resistance), Quicki (Quantitative insulin
sensitivity check index), and FGI (fasting glucose to insu-
lin ratio). The cutoff points used to identify insulin resist-
ance in participants were: fasting insulinemia >12μU/mL
[12]; HOMA–IR > 3.16 [13,14]; Quicki <0.313 [15]; and
FGI <7.0 [15].
The exclusion criteria were as follows: presence of meta-
bolic, endocrine, or genetic disease as reported in patient
records, detected by general and special physical examin-
ation, or in laboratory or radiological procedures, as well as
menstrual cycle changes that indicate the presence of Poly-
cystic Ovary Syndrome (PCOS) in female participants.
Statistical analysis
Data for age, BMI, HDLc, TG, SBP and DBP, fasting Insulin
and glycemia, HOMA-IR, Quicki, and FGI have asymmet-
ric distribution. For comparison between gender-stratified
groups, a generalized linear model (PROC GENMOD from
SAS for Windows V9.2) with gamma distribution was used.
Multiple comparisons were performed using the same pro-
gram. AbdC data have symmetrical distribution and were
analyzed using ANOVA followed by the Tukey test for
gender-stratified groups. The level of significance adopted
was 5%.
Associations between MS criteria, nutritional state,
and BMI data for gender-stratified groups were analyzed
through the Chi-square test or exact Fisher test. In all
tests, significance level was fixed at 5% or the corre-
sponding p value was used.
Results
Out of 321 adolescents enrolled in this study, 95 (29.6%)
were classified as overweight by BMI, 129 (40.2%) as
obese, and 97 (31.2%) as extremely obese. Of these, 174
(54.2%) were female and 147 (45.8%) were male. Table 1
shows nutritional and laboratory results, and the criteria
for MS diagnosis for both female and male participants.
Table 1 Nutritional assessment and laboratory variables for adolescents according to gender
FEMALE OVERWEIGHT (n = 55) OBESE (n = 71) EXTREMELY OBESE (n = 48)
X SD X SD X SD
Age (years) (1) NS 13.28a 2.26 12.66ab 2.05 12.45b 1.61
BMI (kg/m2) (1)** 25.10a 2.62 27.98b 3.07 33.99c 5.17
AbdC (cm) (2)** 82.84a 8.34 87.39b 8.85 95.84c 10.68
HDLc (mg/dL)(1)** 49.24a 9.95 42.19b 8.68 40.53c 13.08
TG (mg/dL) (1)** 92.11a 35.74 107.41b 68.11 121.33bc 46.38
SBP(1)** 110.73a 8.18 116.24b 14.53 127.58c 18.40
DBP(1)** 68.66a 6.89 71.47ab 12.63 81.93c 12.12
Glycemia (mg/dL) (1)NS 82.60a 8.43 83.58a 15.85 82.56a 7.52
Insulin (μU/mL) (1)** 13.78a 4.79 17.58b 10.22 20.38bc 9.50
HOMA-IR(1)** 2.79a 0.99 3.65b 2.26 4.12bc 1.84
Quicki(1)** 0.33a 0.02 0.32b 0.02 0.32bc 0.02
FGI(1)** 7.37a 7.03 5.88b 2.69 5.12bc 3.18
MALE (n = 40) (n = 58) (n = 49)
X SD X SD X SD
Age (years) (1)NS 12.62 a 1.76 12.89a 1.68 12.65 a 2.22
BMI (kg/m2) (1)** 24.07 a 2.12 27.12b 2.69 32.13c 4.11
AbdC (cm) (2)** 81.03a 7.54 86.02ab 10.14 95.19c 11.28
HDLc (mg/dL) (1)NS 43.10a 8.31 44.22a 11.37 44.31a 8.97
TG (mg/dL) (1)NS 103.38a 76.60 95.71ab 58.68 117.83ac 55.34
SBP(1)** 111.17a 15.01 115.16ab 14.10 125.98c 13.06
DBP(1)** 69.28a 10.70 74.73bc 10.20 76.88c 12.17
Glycemia (mg/dL) (1)NS 83.59a 7.22 83.77a 7.90 86.51a 5.79
Insulin (μU/mL) (1)NS 13.72a 9.90 14.08a 7.64 16.13a 8.07
HOMA-IR(1)NS 2.84a 2.03 2.89a 1.62 3.45a 1.71
Quicki(1)** 0.34a 0.04 0.33ab 0.03 0.32b 0.02
FGI(1)** 10.86a 10.43 7.84b 5.99 6.32bc 2.38
Note: (1) Multiple comparison using PROC GENMOD from SAS program.
(2) Multiple comparisons using ANOVA and Tukey test.
* p < 0.05 **p < 0.01 NS not significant.
The same letters show no statistically significant difference.
Total number of female adolescents = 174.
Total number of male adolescents = 147.
BMI Body Mass Index, AbdC Abdominal circumference, HDLc-HDL cholesterol, TGTriglycerides, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, HOMA-IR
Homeostasis model assessment of insulin resistance Quicki Quantitative insulin sensitivity check index, FGI Fasting glucose to insulin ratio.
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in comparisons between overweight, obese, and ex-
tremely obese groups for both male and female partici-
pants (Table 1).
Anthropometric values and MS criteria increased in
direct proportion from the overweight to extremely
obese female adolescent groups. Differences were statis-
tically significant with the exception of glycemia
(Table 1). The highest HDLc values were found in the
overweight girl group, and the lowest values in the ex-
tremely obese girl group (p < 0.0001).
Mean fasting insulinemia values significantly increased
from the overweight to the extremely obese girl group(p < 0.0001). The same was observed for HOMA-IR, where
values increased in direct proportion from the overweight
to extremely obese girl groups (p < 0.0001). The inverse
was observed for Quicki and FGI mean values.
For male adolescents, the variables considered as risk
factors for MS increased in direct proportion from the
overweight to the extremely obese groups. However, no
significant differences were observed for triglycerides,
glycemia, and HDLc values between groups analyzed,
and for fasting insulin and HOMA-IR. Mean Quicki
and FGI values decreased in direct proportion from the
overweight to extremely obese groups (p = 0.0031 and
p < 0.0001).
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to IDF criteria, in all overweight, obese, and extremely
obese adolescent groups classified by BMI and stratified
by gender. Altered abdominal circumference was the
most prevalent factor (55%), followed by reduced HDLc
levels (35%), elevated pressure (21%), and elevated TG
levels (18.5%). According to BMI classification, AbdC
was the most prevalent criteria occurring in 87% of ado-
lescents considered extremely obese.
In females, the most prevalent criterion was altered
AbdC, which varied from 41.9% in the overweight group
to 96.6% in the extremely obese group (p < 0.001), fol-
lowed by decreased HDLc levels, varying from 22.6% in
the overweight group to 51.7% in the extremely obese
group (p = 0.040). Arterial hypertension was the third
most common factor of MS, occurring in 9.7% of over-
weight and in 41.4% of extremely obese girls (p = 0.007).
In males, the most frequent MS factor was abnormal
abdominal circumference, which varied from 21.1% in
the overweight group to 76.0% in the extremely obese
group (p < 0.001). Decreased HDLc was the second most
prevalent, but with no significant difference between
groups, this was followed by hypertension and high tri-
glyceride levels. The prevalence of hypertension was sig-
nificantly higher in extremely obese than in overweight
boys (p = 0.057) (Table 2). For both genders, alteredTable 2 Prevalence of Metabolic Syndrome factors in all over
according to BMI and by gender
General (n = 321) Ove
Total AbdC >90thP (1)** 55.0% 30.4%
TG ≥150 mg/dL(1)* 18.5% 15.9%
HDLc <40 mg/dL(1)NS 35.5% 29.0%
SBP-DBP ≥130/85(1)** 21.0% 10.1%
Glycemia ≥100 mg/dL(2)NS 2.0% 2.9%
(n = 174) (n =
Female AbdC >90thP (2)** 67.0% 41.9%
TG ≥150 mg/dL(2)NS 19.0% 12.9%
HDLc <40 mg/dL(1)* 41.0% 22.6%
SBP-DBP ≥130/85(2)** 21.0% 9.7%
Glycemia ≥100 mg/dL(2)NS 3.0% 3.2%
(n = 147) (n =
Male AbdC >90thP(1)** 43.0% 21.1%
TG ≥150 mg/dL(2)NS 18.0% 18.4%
HDLc <40 mg/dL(1)NS 30.0% 34.2%
SBP-DBP ≥130/85(2)* 21.0% 10.5%
Glycemia ≥100 mg/dL(2)NS 1.0% 2.6%
Note: (1) Chi-square test.
(2) Fisher’s exact test.
* p < 0.05 **p < 0.01 NS not significant.
The same letters show no statistically significant difference.
AbdC Abdominal circumference, HDLc-HDL cholesterol, TG Triglycerides, SBP Systolicglycemia was the least prevalent MS factor in all groups
(Table 2).
When MS was diagnosed following IDF criteria, con-
sidering the presence of at least three out of five meta-
bolic abnormalities, we found that from the 321
adolescents evaluated, 59 (18.3%) were positive for MS,
of whom 32 were female and 27 were male. By the Exact
Fisher test, the highest MS percentages were observed in
the extremely obese groups regardless of gender (41.7%
females and 30.6% males), and differed significantly to
the other groups (p < 0.001 for females and p < 0.0042
for males).
From the 321 adolescents evaluated, 65% presented in-
sulin resistance. Of the different methods used to evalu-
ate insulin resistance, fasting insulinemia and fasting
glucose to insulin ratio (FGI) resulted in the highest per-
centages of insulin-resistant adolescents (Table 3).
Discussion
The prevalence of metabolic syndrome in obese children
and adolescents has increased worldwide. Obese chil-
dren have higher abdominal fat, which is associated with
hyperinsulinism and cardiometabolic alterations such as
low HDLc, increased triglycerides and LDLc, and
increased blood pressure, resulting in increased risk for
type 2 diabetes and cardiovascular diseases [6,9,16-19].weight, obese, and extremely obese adolescents
rweight (n = 95) Obese (n = 129) Extremely obese (n = 97)
a 54.5% b 87.0% c
ab 13.0% a 29.6% b
a 37.7%a 40.7%a
a 18.2% a 38.9% b
a 1.3% a 1.9% a
55) (n = 71) (n = 48)
a 65.0% a 96.6% b
a 15.0% a 31.0% a
a 47.5% ab 51.7% b
a 15.0% a 41.4% b
a 2.5% a 3.4% a
40) (n = 58) (n = 49)
a 43.2% a 76.0% b
a 10.8% a 28.0% a
a 27.0% a 28.0% a
a 21.6% ab 36.0% b
a 0.0% a 0.0% a
Blood Pressure, DBP Diastolic Blood Pressure.
Table 3 Percentage of insulin-resistant adolescents
according to method
Method and reference value General
(n = 321)
Females
(n = 174)
Males
(n = 147)
Insulin ≥12μU/mL 64.0% 74.0% 54.0%
HOMA >3.16 43.5% 54.0% 33.0%
Quicki <0.313 25.0% 32.0% 18.0%
FGI <7.0 65.0% 75.0% 55.0%
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initial clinical and nutritional evaluation of adolescents
when they spontaneously signed up for consultation at
the Adolescent Medicine Outpatient Clinic, which sees
adolescents between 10 and 20 years of age and where
consultations are arranged in advance [where the only
limiting factor is the availability of professionals in this
area to provide consultations]. In the study period, 321
adolescents between 10 and 16 years of age who pre-
sented with excess weight were included in the sample.
We stress again that the participants are from a sample
constructed for convenience, however those making up
the sample were sequentially introduced, a measure
incorporated into the treatment provided at the out-
patient clinic. Therefore our results should be used with
caution in overweight, obese, and extremely obese ado-
lescents from other populations.
We found a high prevalence of overweight, obese, and
extremely obese adolescents, together with a high preva-
lence of cardiometabolic risk factors, such as dyslipide-
mia and blood pressure alterations, in these individuals,
potentially contributing to MS onset at early ages. The
high prevalence of obesity found in this study clearly
reflects the process of nutritional transition occurring in
Brazil, through which undernutrition is replaced by
obesity [20,21]. In a retrospective study of adolescents
who also attended this clinic between 1988 and 1996,
the authors showed that overweight and obesity doubled
in females and more than tripled in males during this
period [22]. Another study reported that the percentage
of individuals who presented MS factors almost doubled
over a ten-year period [19]
Anthropometric measurements, especially abdominal
circumference, are crucial for MS diagnosis. In addition,
measurements of serum lipid fractions, fasting glucose
values, and blood pressure in susceptible or overweight
individuals are also important. Evaluation of fasting insu-
lin has been highlighted, given that a strong association
between basal hyperinsulinemia, blood pressure altera-
tions, and dyslipidemia has been demonstrated. Further-
more, insulin resistance has been indicated as the
physiological basis for MS [23,24], since it precedes dia-
betes, anticipating insulin secretion failure [25]. It has
also been suggested that hyperinsulinemia precedes theappearance of MS in infancy and adolescence, possibly
explaining the association between obesity and the
observed vascular dysfunctions [18].
In this study, an abnormal abdominal circumference
was the most prevalent anthropometric parameter for
both male and female adolescents, being more frequent
in extremely obese females (96.6%) than in extremely
obese males (76%). Of the 321 adolescents analyzed, 31%
had at least one cardiometabolic risk factor, 26% had at
least two, and 25% did not present any of the risk factors.
The prevalence of three or more risk factors was higher
in the extremely obese groups of both genders, at 41.7%
in females and 30.6% in males. A previous study per-
formed in Bogalusa, USA, found that 26% of adolescents
had at least one risk factor and 4% had at least three risk
factors. In extremely obese adolescents, 34% of females
and 32% of males had at least three risk factors [9].
We also observed that the metabolic abnormalities
were more significant and frequent in individuals with
higher BMI values, specifically in obese and extremely
obese adolescents compared to those considered over-
weight. Altered HDLc was the most frequent of the car-
diometabolic parameters, followed by abnormal blood
pressure and triglycerides levels. When the metabolic
abnormalities were analyzed in groups stratified by gen-
der, we observed an increased prevalence in females.
Approximately 50% of extremely obese females had low
HDLc levels and 30% had increased triglycerides. In
males, HDLc was the most frequent (30%) altered car-
diometabolic parameter, followed by increased blood
pressure (21%), the latter being the most prevalent ab-
normality found in extremely obese males, with a fre-
quency of 36%.
When analyzing the variables associated with insulin
resistance, we found significant differences in adolescent
female groups for all criteria. A higher percentage of
girls (75%), than boys (55%), presented insulin resistance
according to FGI values. Moran et al. [26]; Barja et al.
[27]; Jeffery et al. [28] support our findings, as they
stress the influence of sexual dimorphism, which results
from the earlier appearance of secondary sexual charac-
teristics in girls compared to boys, external biological ex-
pression modulated by hormonal ebullience belonging to
the puberty years. For Jeffery et al., HOMA-IR levels
were higher in girls than boys at all evaluated ages, from
7 to 14 years, even after adjustments, presenting their
peak when the adolescents were found in Tanner stage 3
and 4, moments associated with peak height velocity
[28]. Regardless of gender, the extremely obese group
presented the highest degree of insulin resistance. Our
data differ from a previous study in which no significant
differences in fasting insulin values were observed
among eutrophic, overweight, and obese groups [4], pos-
sibly because analyses were conducted according to
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points used in this study for anthropometric and bio-
chemical variables and for insulin resistance are those
recommended by IDF [2] for the studied age band,
found in related international scientific literature [13-
15], stressing that specific values for the Brazilian ado-
lescent population are still not available. We believe that
these values will soon be available as a large population
study called the ERICA study (Study of Cardiovascular
Risks in Adolescents) is being developed.
Considering the IDF criteria for MS diagnosis [2], we
showed that around 18% of the adolescents analyzed
presented the syndrome, which was more prevalent in
extremely obese individuals, especially females.
A study in India with 2640 adolescents of both gen-
ders produced similar results; in eutrophic and over-
weight/obese adolescents, abnormalities in triglycerides,
HDLc, basal insulin, and insulin resistance levels evalu-
ated by HOMA-IR were higher in females. HOMA-IR
values were much higher in individuals presenting para-
meters indicative of MS. Altered cardiometabolic
parameters, of which reduced HDLc and increased
triglycerides were the most common, were more fre-
quent in overweight adolescents. Increased abdominal
circumference was found in approximately 86% of
overweight/obese adolescents [11].
The transversal approach used in this study raises the
question of instability in metabolic syndrome diagnosis.
Considering the intense growth and puberty changes, a
longitudinal follow-up of our study individuals would be
necessary. Nevertheless, studies have shown that 85% of
obese individuals in this age group remain obese in adult-
hood [4,9] and many are diagnosed with MS. Even though
some of these patients do not present the syndrome in the
following years, its diagnosis during childhood and adoles-
cence reinforces the importance of implementing effective
treatment at an early age. Preventive measures aimed at re-
ducing the incidence of obesity and its consequences at
younger ages should also be adopted.
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